| 900 | Welcome Remarks (Co-Chairs) Drs. Christine Brezden-Masley and Tulin Cil |
|
Session 8: The Patient Voice – Surviving Breast CancerModerator: MJ DeCouteau Presentation to include a minimum of 5 min interactivity with audience through Q&A and/or polling questions addressed to audience |
||
| 905 | Patient Voice – Living with Breast Cancer and Thriving Vesna Zic-Côté |
|
Session 9: Optimization Strategies for Individual Based Prognostic FactorsModerator: David Lim Presentation to include a minimum of 3 min interactivity with audience through Q&A and/or polling questions addressed to audience |
||
| 920 | Pathology Update on Breast Biomarkers Brandon Sheffield |
|
| 935 | The Role of Neoadjuvant and Adjuvant Therapies Mita Manna |
|
| 950 | The Surgical Approach to Nodal Disease and Margin Status David Lim |
|
| 1005 | Considerations for Radiation Therapy Jeff Cao |
|
| 1025 | Break and Networking | |
Session 10: Toxicity management of novel therapeuticsModerator: Christine Simmons Presentations followed by a 20 min dedicated Q&A interactivity with audience through Q&A and/or polling questions addressed to audience |
||
| 1040 | Antibody Drug Conjugates Jan-Willem Henning |
|
| 1055 | Immunotherapy and Surgical and Radiation Planning Rami Younan |
|
| 1110 | Cardio-Oncology and the New ESC Guidelines Susan Dent |
|
| 1125 | Management of Lymphedema – A Surgical Perspective Cagdas Duru Siba Haykal |
|
| 1140 | Panel discussion and Q&A | |
Session 11: Best Poster Presentations (10 min each)Moderator: Amanda Roberts Presentation to include a minimum of 3 min interactivity with audience through Q&A and/or polling questions addressed to audience |
||
| 1200 | Top Three Oral Poster Presentations | |
| 1230 | Lunch with exibitors | |
Concurrent I
Survivorship
Moderator: Melinda Wu
Small Group Discussions -Presentation to include a minimum of 3 min interactivity with audience through Q&A with audience. Additional panel discussion as outlined.
| 1330 | Radiology Screening 101: Breast Imaging Updates Supriya Kulkarni |
| 1345 | Survivorship and Surveillance – Clinical Case Melinda Wu |
| 1400 | Sexual Health and Gynecological Symptoms of Menopause Wendy Wolfman |
| 1415 | Lymphedema & Brain Fog Lori Bernstein & Stephanie Phan |
| 1430 | Surveillance and Bone Health while on ET Carol Townsley |
| 1445 | The Microbiome and Dietary Considerations Caroline Kramer |
| 1500 | Panel discussion and Q&A |
| 1530 | Closing Remarks and Evaluations Melinda Wu |
Concurrent II
Surgical Oncology
Moderator: Tulin Cil & Amanda Roberts
Small Group Discussions -Presentation to include a minimum of 3 min interactivity with audience through Q&A with audience. Additional panel discussion as outlined.
| 1330 | An Update on Phyllodes Tumors Andrea Covelli |
| 1345 | Expanded Genetic Testing Raymond Kim |
| 1400 | Post-Mastectomy Radiation following Breast Reconstruction Theodora Koulis |
| 1415 | Update on Lobular Breast Cancer David Lim |
| 1430 | Panel discussion and Q&A Andrea Covelli, Raymond Kim, Theodora Koulis, David Lim |
| 1445 | Update on Breast MRI Vivianne Freitas |
| 1500 | What’s New in Oncoplastic Surgery? Jessica Maxwell |
| 1515 | The Aesthetic Mastectomy Adena Scheer |
| 1530 | Panel discussion and Q&A Vivianne Freitas, Adena Scheer, Jessica Maxwell |
| 1545 | Closing remarks and evaluations Tulin Cil & Amanda Roberts |